HIV / AIDS in the News

Biopharma firm Gilead announces lenacapavir licensing for HIV treatment - The Indian Express

 

HIV is back; there has been a 30% surge in 2 years; is it that fatal now? - The Economic Times

 

Brain abscess caused by Nocardia farcinica in a person living with HIV - BMC Infectious Diseases

 

Bottleneck breakthrough - Fred Hutchinson Cancer Center

 

GILD Grants Right for HIV PrEP Candidate to Six Generic Companies - Yahoo Finance

 

Gilead Partners With Generics Developers to Provide HIV Drug to Low-Income Countries - BioSpace

 

Understanding Your HIV Self-Test Results - Longview News-Journal

 

Indian pharma firms sign deal to produce, sell generic HIV drug lenacapavir - India Today

 

Lifesaving Gilead HIV drug to be sold as far cheaper generic in Africa and Asia - Semafor

 

PrEPared: PrEP is highly effective HIV Prevention - Longview News-Journal

 

Just the Numbers: The Impact of Dutch International Assistance for Family Planning and HIV, 2024 - Guttmacher Institute

 

Gilead strikes deal to expand HIV drug access in 120 countries - pharmaphorum

 

Gilead Urged To Expand Voluntary Licences For Its Breakthrough HIV Treatment - Health Policy Watch

 

HIV prevention: why a new injectable drug could be such a breakthrough – podcast - The Conversation Indonesia

 

Host cell glycosylation selects for infection with CCR5- versus CXCR4-tropic HIV-1 - Nature.com

 

Gilead signs agreements to facilitate access to HIV prevention drug - Yahoo Finance

 

Gilead signs agreements to facilitate access to HIV prevention drug - Pharmaceutical Technology

 

‘Gamechanger’ HIV prevention drug to be made available cheaply in 120 countries - The Guardian

 

A Promising Injectable for HIV Prevention - Yale School of Medicine

 

Addressing HIV Disparities in Native American Communities - University of New Mexico

 

Emcure Pharmaceuticals partners with Gilead Sciences to produce HIV prevention drug Lenacapavir - economictimes.com

 

Can mosquitoes spread HIV? Here’s what you need to know - The Times of India

 

Rise in HIV diagnoses in UK puts goal of ending transmission by 2030 in “jeopardy” - Queerty

 

Surprise! The Copay for PrEP Just Disappeared - Medpage Today

 

Gilead licenses HIV-prevention drug to generic drugmakers - GMA News Online

 

Gilead licenses HIV-prevention drug to generic drugmakers - Medical Xpress

 

UNAIDS response to Gilead’s announcement on signing voluntary licensing agreements on lenacapavir with six generic manufacturers - UNAIDS

 

Gilead strikes licensing deals with 6 generics makers to boost access to long-acting HIV PrEP med - FiercePharma

 

From Criminalization to Compassion: The Evolution of HIV Laws - AJMC.com Managed Markets Network

 

Dr. Reddy’s, Hetero ink deal with Gilead to make, market generic HIV drug lenacapavir - The Hindu